-

Henry Schein Received Validation of Net-Zero Science-Based Targets

Company Commits to Science-Based Targets to Guide Pathway for Achieving Net-Zero Emissions by 2050

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, announced today that the Science Based Targets initiative (SBTi) has approved the Company’s near-term and long-term science-based emissions reduction targets and has verified Henry Schein’s net-zero science-based target by 2050.

“Sustainability is deeply rooted in our corporate culture, and we understand our role in mitigating our environmental impact, as climate change is one of today’s most important sustainability issues,” says Jennifer Kim Field.

Share

“Having joined the Business Ambition for 1.5⁰C initiative in 2021, Henry Schein is pleased to fulfill our commitment to set net-zero emissions reduction targets. Sustainability is deeply rooted in our corporate culture, and we understand our role in mitigating our environmental impact, as climate change is one of today’s most important sustainability issues,” says Jennifer Kim Field, Chief Sustainability Officer at Henry Schein. “Our validated science-based targets bring us closer to realizing our Company’s mission to make the world healthier, together – which needs to be done in collaboration with health care professionals in order to have a healthier planet for healthier people.”

To achieve the near-term science-based targets, Henry Schein, Inc. commits to:

  • Reduce absolute scope 1 GHG (greenhouse gas) emissions by 42% by 2030 from a 2022 base year
  • Increase active annual sourcing of renewable electricity from 0% in 2022 to 100% by 2030
  • Reduce scope 3 GHG emissions by 51.6% per million USD value added (gross profit) by 2030 from a 2022 base year.

The committed net-zero targets include:

  • Reducing absolute scope 1 GHG emissions by 90% by 2050 from a 2022 base year
  • Continuing active annual sourcing of 100% renewable electricity through 2030
  • Reducing scope 3 GHG emissions by 97% per million USD value added (gross profit) by 2050 from a 2022 base year.

To learn more about Henry Schein’s sustainability and corporate citizenship efforts and to view the Company’s 2023 CARES report, please visit www.henryschein.com/corporatecitizenship.

About Henry Schein, Inc.
Henry Schein, Inc. (Nasdaq: HSIC) is a solutions company for health care professionals powered by a network of people and technology. With approximately 25,000 Team Schein Members worldwide, the Company's network of trusted advisors provides more than 1 million customers globally with more than 300 valued solutions that help improve operational success and clinical outcomes. Our Business, Clinical, Technology, and Supply Chain solutions help office-based dental and medical practitioners work more efficiently so they can provide quality care more effectively. These solutions also support dental laboratories, government and institutional health care clinics, as well as other alternate care sites.

Henry Schein operates through a centralized and automated distribution network, with a selection of more than 300,000 branded products and Henry Schein corporate brand products in our distribution centers.

A FORTUNE 500 Company and a member of the S&P 500® index, Henry Schein is headquartered in Melville, N.Y., and has operations or affiliates in 33 countries and territories. The Company's sales reached $12.7 billion in 2024 and have grown at a compound annual rate of approximately 11.2 percent since Henry Schein became a public company in 1995.

For more information, visit Henry Schein at www.henryschein.com, Facebook.com/HenrySchein, Instagram.com/HenrySchein, LinkedIn.com/Company/HenrySchein, and @HenrySchein on X.

Contacts

Stefanie Fleige
Director, Corporate Media Relations – EMEA, Henry Schein
Email: Stefanie.Fleige@henryschein.de
Phone: +49 172 6433548

Lauren DelGuidice
Senior Corporate Media Relations Specialist – North America, Henry Schein
Email: Lauren.DelGuidice@henryschein.com
Phone: +1 631-479-7309

Henry Schein, Inc.

NASDAQ:HSIC

Release Versions

Contacts

Stefanie Fleige
Director, Corporate Media Relations – EMEA, Henry Schein
Email: Stefanie.Fleige@henryschein.de
Phone: +49 172 6433548

Lauren DelGuidice
Senior Corporate Media Relations Specialist – North America, Henry Schein
Email: Lauren.DelGuidice@henryschein.com
Phone: +1 631-479-7309

Social Media Profiles
More News From Henry Schein, Inc.

Henry Schein Announces Completion of Strategic Investment by KKR and Appointment of Dan Daniel to Board of Directors

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, today announced the successful completion of a $250 million strategic investment by funds affiliated with KKR, a leading global investment firm. Upon the closing of this transaction, KKR has become the holder of approximately 12% of the common shares of Henry Schein. In connection with the investment, William K. “Dan” Daniel,...

Henry Schein to Participate in Upcoming Investor Conference in June

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc., the world’s largest provider of health care solutions to office-based dental and medical practitioners, announced today that the Company will present at the following investor conference in June: Jefferies Global Healthcare Conference at the Marriott Marquis hotel, New York City, on June 4, 2025, at 1:20 p.m. Eastern time. Henry Schein’s presentations can be heard via live webcast by visiting https://investor.henryschein.com/webcasts. Replays...

Henry Schein to Participate in Upcoming Investor Conferences in May

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc., the world’s largest provider of health care solutions to office-based dental and medical practitioners, announced today that the Company will present at the following investor conferences in May: Bank of America Healthcare Conference at the Encore Hotel in Las Vegas on May 14, 2025, at 10:00 a.m. Pacific time (1:00 p.m. Eastern time). Stifel Jaws & Paws Conference at Lotte Hotel, New York City, on May 29, 2025, at 12:40 p.m. Eastern time....
Back to Newsroom